HOME
    
   EN   AR   RU
 

 

GlaxoSmithKline

The group GSK has a challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better and live longer. This mission gives us the purpose to develop innovative medicines, vaccines and products that help millions of people around the world.

Headquartered in the UK, GSK compromises 3 divisions:

  1. GSK Pharma: research and production of medicines that treat major diseases such as asthma, anti-virals, infections, mental health, diabetes, cardiovascular and digestive conditions. In addition, we are a leader in the important area of vaccines developing new treatments for cancer.
  2. Consumer Healthcare: produces and markets oral healthcare and nutritional products and over-the-counter medicines (sensodyne, aquafresh, Niquitin...)
  3. GSK Vaccines: research, development and production of prophylactic and therapeutic vaccines for all ages.

GSK business employs 97,000 people in over 100 countries.

GSK Vaccines, the Global Vaccines Solution Provider

GSK Vaccines, a division of the GlaxoSmithKline Group, is one of the main global players in the research, development and production of prophylactic and therapeutic vaccines. We employ more than 12,200 people including 2,500 working on research activities.

GSK's global vaccine headquarters is in Belgium with 7,800 employees. Our research and development activities and our 14 manufacturing sites are spread throughout the entire world.

Our portfolio comprises 30 marketed vaccines and more than 20 candidate vaccines in development.  One-third of vaccine candidates in our pipeline target diseases particularly prevalent in the developing world, including all three WHO infectious disease priorities: HIV, malaria (Phase III results published in 2011) and tuberculosis. We are committed to providing vaccines to everyone who needs them, no matter where they live. 
 
Last year, we distributed 1.1 billion doses of our vaccines in 173 countries. This represents approximately 3 million doses a day. Over 80 % of these doses went to developing countries, where they are supplied at prices as low as 10-20 % of those in developed countries. We are one of the main suppliers of vaccines to organisations such as UNICEF and the Pan American Health Organisation (PAHO).

GSK's vaccines business put the customer at the heart of everything we do. That is why we define our vaccines mission as Protecting.Human.Kind.

 

Pascal Lizin, Director External & Public Affairs GSK Vaccines

President Essenscia Wallonia

Contact details

GSK
Avenue Pascal 2-4-6
B-1300 Wavre
T: +32 (0)10 85 85 00
www.gsk.com


GSK Vaccines
Avenue Fleming 20
B- 1300 Wavre
T: +32 (0)10 85 95 11
www.gsk.com